Claim59022fce832d58171d6cbb05b2f87ed302610d56af11a472c83aee638143e1a0·My Arguments

Claim

The most feared serious long-term harms — medullary/thyroid C-cell cancer, pancreatic cancer, and other obesity-related cancers — have not shown statistically significant elevation in pooled randomized and cohort data to date, though absolute event counts are small and dedicated cancer-outcome studies beyond ~2-4 years are still lacking.

Evidence (1)

Assessing the oncological safety of GLP-1 receptor agonists: systematic review and meta-analysis
No statistically significant increase in thyroid, pancreatic, or obesity-related cancer risk in pooled data; authors note longer cancer-focused follow-up is still needed.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12676983/

Embed this claim

<iframe
  src="https://www.isonomia.app/embed/claim/59022fce832d58171d6cbb05b2f87ed302610d56af11a472c83aee638143e1a0"
  width="600"
  height="280"
  frameborder="0"
  style="border: 1px solid #e5e7eb; border-radius: 8px;"
  title="Isonomia Claim"
  loading="lazy"
></iframe>

Copy and paste into any website or forum that supports HTML.

Respond to this claim on Isonomia

Build or challenge arguments with structured reasoning in the Digital Agora.

View full deliberationJoin & respond